Developing safe, convenient, disease-modifying treatments for food allergies.
Currently ongoing clinical trials of PVX108 for Peanut Allergy
Phase 2 Studies: AVX-201
(currently recruiting)
​
AVX-201 is a double blind randomised Phase 2 study in adolescents and children with peanut allergy. The aims of the trial are to evaluate the efficacy and safety of PVX108 when administered intradermally in monthly doses over a 12 month period. The AVX-201 trial is being run under an IND and is currently recruiting at clinics in Australia and the United States.
Interested in participating?
Find out more on ClinicalTrials.gov or contact the trial centre nearest you (details below)
Australia
New South Wales
Enrolment complete
​Children's Hospital at Westmead
Westmead, NSW 2145
SCHN-CHW-AllergyResearch@health.nsw.gov.au
Enrolment complete
Sydney Children's Hospital
Randwick, NSW 2031
Queensland
Enrolment complete
​
Queensland Children's Hospital
South Brisbane, QLD 4101
South Australia
Enrolment complete
​
Women's and Children's Hospital, Adelaide
North Adelaide, SA 5006
Victoria
Enrolment complete
Murdoch Children's Research Institute,
Royal Children's Hospital
Melbourne Parkville, VIC 3052
United States
Arkansas
Enrolment complete
​
Arkansas Children's Research Institute
Little Rock, Arkansas, 72202
California
Enrolment complete
Peninsula Research Associates
Rolling Hills Estates, California, 90274
Georgia
Enrolment complete
​
Children's Healthcare of Atlanta
Atlanta, Georgia, 30329
Indiana
Enrolment complete
​
Riley Children's Hospital at IU
Indianapolis, Indiana, 462020
Maryland
Enrolment complete
​
IAA Clinical Research
Chevy Chase, Maryland, 20815
Massachusetts
Enrolment complete
​
Massachusetts General Hospital
Boston, Massachusetts, 02114
North Carolina
Enrolment complete
​
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
Western Australia
Enrolment complete
​
Perth Children's Hospital
Nedlands, WA 6009